Latest Breaking News On - கேன் பார்மா - Page 1 : comparemela.com

NervGen Pharma Corp.: NervGen Pharma Grants Stock Options Vancouver, British Columbia (Newsfile Corp. - July 16, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ( NervGen or the Company ), a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, today announced that the Company has granted 125,000 incentive stock options to existing consultants providing investor relations services, 25,000 of which are exercisable at a price of $1.75 per share and 100,000 of which are exercisable at $2.00 per share for a period of three years and that vest equally every three months over a one-year period. All options have been granted in accordance with the policies of the TSX Venture Exchange and the conditions of the Company s stock option plan.

United kingdomBritish columbiaKostenloser wertpapierhandelNancy thompsonHuitt traceyLinkedin nervgen pharma corpCorporate communicationsBritish columbia newsfile corpRegulation services providerNervgen pharma corpVenture exchangeGen pharmaVorticom publicஒன்றுபட்டது கிஂக்டம்பிரிட்டிஷ் கொலம்பியாநான்சி தாம்சன்